Abstract: Models of Coronavirus Pathogenesis
Coronaviruses and arteriviruses infect multiple species of mammals, including humans, causing diseases that range from encephalitis to enteritis. Several of these viruses infect domestic animals and cause significant morbidity and mortality, leading to major economic losses. In this category are included such pathogens as transmissible gastroenteritis virus, porcine respiratory and reproductive virus and infectious bronchitis virus. The feline coronaviruses (FECV) generally do not cause infections with high morbidity but in a small percentage of cases, the virus mutates to become more virulent. This virus, feline infectious peritonitis virus (FIPV), causes severe disease in young cats. This disease is in large part immunopathological and understanding it is a major goal of Coronavirus research.
Chapter PDF
Similar content being viewed by others
Keywords
- Cell Epitope
- Infectious Bronchitis Virus
- Mouse Hepatitis Virus
- Acute Encephalitis
- Feline Infectious Peritonitis Virus
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Barac-Latas, V., Suchanek, G., Breitschopf, H., Stuehler, A., Wege, H., and Lassmann, H., 1997, Patterns of oligodendrocyte pathology in coronavirus-induced subacute demyelinating encephalomyelitis in the Lewis rat, Glia 19: 1–12.
Barnett, E. and Perimän, S., 1993, The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM, Virology 194: 185–191.
Bergmann, C, McMillan, M., and Stohlman, S. A., 1993, Characterization of the Ld-restricted cytotoxic T-lym-phocyte epitope in the mouse hepatitis virus nucleocapsid protein, J. Virol 67: 7041–49.
Bergmann, C. C, Yao, Q., Lin, M., and Stohlman, S. A., 1996, The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted CTL response, J. Gen. Virol. 77. 315–325.
Buchmeier, M. J., Lewicki, H. A., Talbot, P. J., and Knobler, R. L., 1984, Murine hepatitis virus-4 (strain JHM)-in-duced neurologic disease is modulated in vivo by monoclonal antibody, Virology 132: 261–270.
Castro, R. F. and Perimän, S., 1995, CD8+ T cell epitopes within the surface glycoprotein of a neurotropic Coronavirus and correlation with pathogenicity, J. Virol. 69: 8127–8131.
Cheever, F. S., Daniels, J. B., Pappenheimer, A. M., and Bailey, O. T., 1949, A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin, J. Exp. Med. 90: 181–194.
Chen, W. and Baric, R., 1996, Molecular anatomy of MHV persistence: coevolution of increased host resistance and virus virulence, J. Virol. 70: 3947–3960.
Dalziel, R. G., Lampert, P. W., Talbot, P. J., and Buchmeier, M. J., 1986, Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence, J. Virol. 59: 463–171.
Dorries, R., Watanabe, R., Wege, H., and ter Meulen, V., 1986, Murine coronavirus-induced encephalomyelitides in rats: Analysis of immunoglobulins and virus-specific antibodies in serum and cerebrospinal fluid, J. Neuroimmunol. 12: 131–142.
Fleming, J. O., Trousdale, M. D., Bradbury, J., Stohlman, S. A., and Weiner, L. P., 1987, Experimental demyelination induced by Coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease, Microb. Pathog. 3: 9–20.
Flory, E., Stuhler, A., Barac-Latas, V., Lassmann, H., and Wege, H., 1995, Coronavirus-induced encephalomyelitis: balance between protection and immunopathology depends on the immunization schedule with spike protein S, J. Gen. Virol 76: 873–879.
Gombold, J., Sutherland, R., Lavi, E., Paterson, Y., and Weiss, S. R., 1995, Mouse hepatitis virus A59-inducedde-myelination can occur in the absence of CD8+ T cells, Microb. Pathog. 18: 211–221.
Haspel, M. V., Lampert, P. W., and Oldstone, M. B. A., 1978, Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination, Proc. Natl. Acad. Sei. USA 75: 4033–4036.
Heemskerk, M., Schoemaker, H., De Jong, I., Schijns, V., Spaan, W., and Boog, C. J. P., 1995, Differential activation of mouse hepatitis virus-specific CD4+ cytotoxic T cells is defined by peptide length, Immunology 85: 517–522.
Heemskerk, M., Schoemaker, H., Spaan, W., and Boog, C, 1995, Predominance of MHC class II-restricted CD4+ cytotoxic T cells against mouse hepatitis virus A59, Immunology 84: 521–527.
Houtman, J. J. and Fleming, J. O., 1996, Dissociation of demyelination and viral clearance in congenitally immu-nodeficient mice infected with murine Coronavirus JHM, J. Neurovirology 2: 101–110.
Jacobsen, G. and Perimän, S., 1990, Localization of virus and antibody response in mice infected persistently with MHV-JHM, Adv. Exp. Med. Biol. 276: 573–578.
Jordan, C, Friedrich, V., Godfraind, C, Caardellechio, C, Holmes, K., and Dubois-Dalcq, M., 1989, Expression of viral and myelin gene transcripts in a murine CNS demyelinating disease caused by a Coronavirus, Glia 2:318–329.
Körner, H., Schliephake, A., Winter, J., Zimprich, F., Lassmann, H., Sedgwick, J., Siddell, S., and Wege, H., 1991, Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells, J. Immunol. 147: 2317–2323.
Kyuwa, S. and Stohlman, S. A., 1990, Pathogenesis of a neurotropic murine coronvirus, strain JHM in the central nervous system of mice, Sem. Virol. 1, 273–280.
Lampert, P. W., Sims, J. K., and Kniazeff, A. J., 1973, Mechanism of demyelination in JHM virus encephalomyelitis, Acta Neuropathol. 24: 76–85.
Lane, T. E., Paoletti, A. D., and Buchmeier, M. J., 1997, Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine Coronavirus, J. Virol. 71: 2202–2210.
Lavi, E., Fishman, P. S., Highkin, M. K., and Weiss, S. R., 1988, Limbic encephalitis after inhalation of a murine Coronavirus, Lab. Invest. 58: 31–36.
Lavi, E., Gilden, D., Highkin, M., and Weiss, S. R., 1986, The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation, Lab. Invest. 36: 130–135.
Lavi, E., Gilden, D., Wroblewska, Z., Rorke, L., and Weiss, S., 1984, Experimental demyelination produced by the A59 strain of MHV, Neurology 34: 597–603.
Lipton, H. L., Twaddle, G., and Jelachich, M. L., 1995, The predominant virus antigen burden is present in macrophages in Theiler’s murine encephalomyelitis virus-induced demyelinating disease, J. Virol. 69: 2525–2533.
Mobley, J., Evans, G., Dailey, M. O., and Perimän, S., 1992, Immune response to a murine Coronavirus: Identification of a homing receptor-negative CD4+ T cell subset that responds to viral glycoproteins, Virology 187: 443–452.
Nagashima, K., Wege, H., Meyermann, R., and ter Meulen, V., 1978, Coronavirus induced subacute demyelinating encephalomyelitis in rats: A morphological analysis, Acta Neuropathol. 44: 63–70.
Nakanaga, K., Yamanouchi, K., and Fujiwara, K., 1986, Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice, J. Virol. 59: 168–171.
Parker, S. E., Gallagher, T. M., and Buchmeier, M. J., 1989, Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus, Virology 173: 664–673.
Pearce, B. D., Hobbs, M. V., McGraw, T. S., and Buchmeier, M. J., 1994, Cytokine induction during T-cell-medi-ated clearance of mouse hepatitis virus from neurons in vivo, J. Virol. 68: 5483–5495.
Periman, S. and Ries, D., 1987, The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM, Microb. Pathog. 3: 309–314.
Periman, S., Schelper, R., Boiger, E., and Ries, D., 1987, Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody, Microb. Pathog. 2, 185–194.
Pewe, L., Wu, G., Barnett, E. M., Castro, R., and Periman, S., 1996, Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease, Immunity 5: 253–262.
Rowe, C. L., Baker, S. C, Nathan, M. J., and Fleming, J. O., 1997, Evolution of mouse hepatitis virus: Detection and characterization of SI deletion variants during persistent infection, J. Virol 71: 2959–2967.
Sorensen, O., Coulter-Mackie, M., Puchalski, S., and Dales, S., 1984, In vivo and in vitro model of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases, Virology 137: 347–357.
Sorensen, O., Perry, D., and Dales, S., 1980, In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats, Arch. Neurol. 37: 478–484.
Stohlman, S. A., Bergmann, C. C, van der Veen, R. C, and Hinton, D. R., 1995, Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system, J Virol. 69: 684–694.
Stohlman, S. A., Fleming, J. O., Brayton, P. R., Weiner, L. P., and Lai, M. M. C, 1982, Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain,J. Gen. Virol. 63: 265–275.
Stohlman, S. A. and Frelinger, J. A., 1978, Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM, Immunogenetics 6: 277–281.
Stohlman, S. A., Hinton, D. R., Cua, D., Dimacali, E., Sensintaffar, J., Hofman, F. M., Tahara, S. M., and Yao, Q., 1995, Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis, J. Virol. 69: 5898–5903.
Stohlman, S. A., Kyuwa, S., Polo, J. M., Brady, D., Lai, M. M. C, and Bergmann, C. C, 1993, Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain, J. Virol. 67: 7050–7059.
Stohlman, S. A., Matsushima, G. K., Casteel, N., and Weiner, L. P., 1986, In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication, J. Immunol. 136: 3052–3056.
Stohlman, S. A. and Weiner, L. P., 1981, Chronic central nervous system demyelination in mice after JHM virus infection, Neurology 31: 38–44.
Sun, N., Grzybicki, D., Castro, R., Murphy, S., and PerimAn, S., 1995, Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic Coronavirus, Virology 213: 482–493.
Taguchi, F., Siddell, S., Wege, H., and ter Meulen, V., 1985, Characterization of a variant virus selected inrat brains after infection by Coronavirus MHV JHM, J. Virol. 54: 429–435.
Tardieu, M., Boespflug, O., and Barbe, T., 1986, Selective tropism of a neurotropic Coronavirus for epndymal cells, neurons and meningeal cells, J. Virol. 60: 574–582.
Van der Veen, R. C, 1996, Immunogenicity of JHM virus proteins: Characterization of a CD4+ T cell epitope on nucleocapsid protein which induces different T-helper cell subsets, Virology 225: 339–346.
Wang, F., Stohlman, S. A., and Fleming, J. O., 1990, Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated, J. Neuroimmunol. 30: 31–41.
Watanabe, R., Wege, H., and ter Meulen, V, 1983, Adoptive transfer of EAE-like lesions from rats with Coronavirus-induced demyelinating encephalomyelitis, Nature 305: 150–153.
Watanabe, R., Wege, H., and ter Meulen, V, 1987, Comparative analysis of Coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats, Lab. Invest. 57: 375–384.
Wege, H., Schliephake, A., Korner, H., Flory, E., and Wege, H., 1993, An immunodominant CD4+ T cell site on the nucleocapsid protein of murine Coronavirus contributes to protection against encephalomyelitis, J. Gen. Virol. 74: 1287–1294.
Weiner, L. P., 1973, Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus), Arch. Neurol. 28:298–303.
Williams, R. K., Jiang, G., and Holmes, K. V, 1991, Receptor for mouse hepatitis virus is a member of the carci-noembryonic antigen family of glycoproteins, Proc. Natl. Acad. Sei. USA 88: 5533–5536.
Williamson, J. S. and Stohlman, S. A., 1990, Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells, J. Virol. 64: 4589–4592.
Xue, S., Jaszewski, A., and Perimän, S., 1995, Identification of a CD4+ T cell epitope within the M protein of a neurotropic Coronavirus, Virology 208: 173–179.
Yamaguchi, K., Goto, N., Kyuwa, S., Hayami, M., and Toyoda, Y, 1991, Protection of mice from a lethal Coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones, J. Neuroimmunol. 32: 1–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Perlman, S. (1998). Pathogenesis of Coronavirus-Induced Infections. In: Enjuanes, L., Siddell, S.G., Spaan, W. (eds) Coronaviruses and Arteriviruses. Advances in Experimental Medicine and Biology, vol 440. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5331-1_65
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5331-1_65
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7432-9
Online ISBN: 978-1-4615-5331-1
eBook Packages: Springer Book Archive